S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q3 2022

BVF Partners

Periodo: Q3 2022 Β· Depositato: 2022-11-14
Vedi su SEC EDGAR β†—
AUM
$2.42B
Valore totale del portafoglio
Posizioni
80
Titoli dichiarati
Prima Posizione
MLTX
7.2% $173.1M
Var. Trimestrali
+4 / -3
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-11-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
MLTXMOONLAKE IMMUNOTHERAPEUTICS$173.1M7.15%$7.76$18.95+144.2%
7.2%
IONSIONIS PHARMACEUTICALS INC$127.1M5.25%$44.23$81.80+84.9%
5.3%
GHRSGH RESEARCH PLC$107.8M4.45%$11.62$27.01+132.4%
4.5%
KYMRKYMERA THERAPEUTICS INC$102.2M4.22%$21.77$113.51+421.4%
4.2%
RPTXREPARE THERAPEUTICS INC$100.6M4.15%β€”β€”
4.2%
RLAYRELAY THERAPEUTICS INC$97.1M4.01%$22.37$18.65-16.6%
4.0%
CGEMCULLINAN ONCOLOGY INC$96.3M3.98%$12.82$17.63+37.5%
4.0%
RLMDRELMADA THERAPEUTICS INC$76.9M3.18%$37.02$6.28-83.0%
3.2%
CRNXCRINETICS PHARMACEUTICALS IN$72.3M2.98%$19.64$42.23+115.0%
3.0%
RCUSARCUS BIOSCIENCES INC$71.1M2.94%$26.16$30.33+15.9%
2.9%
MRUSMERUS N V$69.0M2.85%β€”β€”
2.9%
THRDTHIRD HARMONIC BIO INC$66.4M2.74%β€”β€”
2.7%
XOMAXOMA CORP DEL$64.7M2.67%$17.91$43.00+140.1%
2.7%
RVMDREVOLUTION MEDICINES INC$64.2M2.65%$19.72$189.24+859.6%
2.6%
ACRSACLARIS THERAPEUTICS INC$62.6M2.59%$15.74$5.56-64.7%
2.6%
CTICCTI BIOPHARMA CORP$51.3M2.12%β€”β€”
2.1%
IDYAIDEAYA BIOSCIENCES INC$49.2M2.03%$14.92$37.65+152.3%
2.0%
KURAKURA ONCOLOGY INC$43.8M1.81%$13.66$11.10-18.7%
1.8%
PNTPOINT BIOPHARMA GLOBAL INC$43.2M1.78%β€”β€”
1.8%
SNDXSYNDAX PHARMACEUTICALS INC$43.2M1.78%$24.03$21.82-9.2%
1.8%
CINCCINCOR PHARMA INC$43.1M1.78%β€”β€”
1.8%
LXRXLEXICON PHARMACEUTICALS INC$38.8M1.60%$2.40$2.32-3.3%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$35.7M1.48%$20.51$19.40-5.4%
1.5%
ITOSITEOS THERAPEUTICS INC$34.5M1.42%β€”β€”
1.4%
XENEXENON PHARMACEUTICALS INC$32.5M1.34%$36.10$60.96+68.9%
1.3%
NUVLNUVALENT INC$32.4M1.34%$19.44$123.73+536.5%
1.3%
FDMT4D MOLECULAR THERAPEUTICS IN$32.2M1.33%$8.04$13.00+61.7%
1.3%
COGTCOGENT BIOSCIENCES INC$31.1M1.28%$14.92$38.69+159.3%
1.3%
ALLKALLAKOS INC$30.6M1.27%β€”β€”
1.3%
EQRXEQRX INC$29.7M1.23%β€”β€”
1.2%

AttivitΓ  Trimestre su Trimestre

Q3 2022 vs. Q2 2022

Nuove Posizioni (4)

TickerEmittenteNozionale
THRDTHIRD HARMONIC BIO INC$66.4M
ALLKALLAKOS INC$30.6M
VERVVERVE THERAPEUTICS INC$22.3M
VIGLVIGIL NEUROSCIENCE INC$16.5M

Posizioni Chiuse (3)

TickerEmittenteNozionale
PTGXPROTAGONIST THERAPEUTICS INC$8.8M
CLDXCELLDEX THERAPEUTICS INC NEW$4.2M
VYGRVOYAGER THERAPEUTICS INC$0.8M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
EPIXESSA PHARMA INC$4.3M+136.5%
SLNSILENCE THERAPEUTICS PLC$7.0M+126.3%
IONSIONIS PHARMACEUTICALS INC$79.8M+125.1%+84.9%
PNTPOINT BIOPHARMA GLOBAL INC$20.3M+66.0%
RVMDREVOLUTION MEDICINES INC$20.2M+44.3%+859.6%
RLMDRELMADA THERAPEUTICS INC$45.4M+25.3%-83.0%
IDYAIDEAYA BIOSCIENCES INC$10.6M+17.9%+152.3%
LXRXLEXICON PHARMACEUTICALS INC$12.4M+14.1%-3.3%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CFRXCONTRAFECT CORP$-12.1M-88.1%
GBIOGENERATION BIO CO$-8.3M-76.7%
EQRXEQRX INC$-20.2M-43.6%
XENEXENON PHARMACEUTICALS INC$-16.1M-43.6%+68.9%
SPROSPERO THERAPEUTICS INC$1.6M-37.6%
RCUSARCUS BIOSCIENCES INC$-29.3M-31.4%+15.9%
SNDXSYNDAX PHARMACEUTICALS INC$-2.1M-23.7%-9.2%
CINCCINCOR PHARMA INC$12.1M-20.2%
← Torna agli Hedge Fund